File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: The Adjunctive Effect of Acupuncture for Advanced Cancer Patients in a Collaborative Model of Palliative Care: Study Protocol for a 3-Arm Randomized Trial

TitleThe Adjunctive Effect of Acupuncture for Advanced Cancer Patients in a Collaborative Model of Palliative Care: Study Protocol for a 3-Arm Randomized Trial
Authors
Keywordsacupuncture
cancer related symptoms
palliative care
quality of life
randomized controlled trial
Issue Date2021
PublisherSAGE Publications (UK and US): Open Access Titles. The Journal's web site is located at http://www.sagepub.com/journalsProdDesc.nav?prodId=Journal201510
Citation
Integrative Cancer Therapies, 2021, v. 20, p. article no. 15347354211012749 How to Cite?
AbstractBackground: Cancer is the second leading cause of death before the age of 70. Improved cancer survival has put increasing demands on cancer care. Palliative care is the specialized multi-disciplinary care providing relief from the pain, symptoms, and stress of serious illness. The study aims to evaluate the adjunctive effect of acupuncture for advanced cancer patients in a collaborative model of palliative care. Methods/Design: This is a single-blinded, randomized, sham-controlled trial. One hundred twenty advanced cancer patients undergoing palliative care will be randomized in a ratio of 2:1:1 to manual acupuncture plus standard care group (ASC), sham acupuncture plus standard care group (SSC), and standard care group (SC). Patients in ASC and SSC will receive 9 sessions of acupuncture or sham acupuncture for 3 weeks, and will be followed up for 2 months. The primary measure is the change from baseline score of the Edmonton Symptom Assessment System at 3 weeks. The secondary measures include the Brief Fatigue Inventory, Hospital Anxiety and Depression Scale, Insomnia Severity Index, Numeric Rating Scale, and European Organization for Research and Treatment of Cancer Quality of Life 15 items Questionnaire for Palliative Care. Discussion: The finding of this trial will provide high-quality evidence on the adjunctive effect of acupuncture to standard care on advanced cancer patients undergoing palliative care. Trial Registration: Clinicaltrials.gov, NCT04398875 (https://www.clinicaltrials.gov/ct2/show/NCT04398875), Registered on 21 May 2020.
Persistent Identifierhttp://hdl.handle.net/10722/302115
ISSN
2023 Impact Factor: 2.9
2023 SCImago Journal Rankings: 0.687
PubMed Central ID

 

DC FieldValueLanguage
dc.contributor.authorChen, H-
dc.contributor.authorSo, TH-
dc.contributor.authorCho, WCS-
dc.contributor.authorQin, Z-
dc.contributor.authorMa, CH-
dc.contributor.authorLi, SG-
dc.contributor.authorYang, Z-
dc.contributor.authorJiang, F-
dc.contributor.authorWu, J-
dc.contributor.authorZhang, ZJ-
dc.contributor.authorKong, FM-
dc.contributor.authorLao, L-
dc.date.accessioned2021-08-21T03:31:48Z-
dc.date.available2021-08-21T03:31:48Z-
dc.date.issued2021-
dc.identifier.citationIntegrative Cancer Therapies, 2021, v. 20, p. article no. 15347354211012749-
dc.identifier.issn1534-7354-
dc.identifier.urihttp://hdl.handle.net/10722/302115-
dc.description.abstractBackground: Cancer is the second leading cause of death before the age of 70. Improved cancer survival has put increasing demands on cancer care. Palliative care is the specialized multi-disciplinary care providing relief from the pain, symptoms, and stress of serious illness. The study aims to evaluate the adjunctive effect of acupuncture for advanced cancer patients in a collaborative model of palliative care. Methods/Design: This is a single-blinded, randomized, sham-controlled trial. One hundred twenty advanced cancer patients undergoing palliative care will be randomized in a ratio of 2:1:1 to manual acupuncture plus standard care group (ASC), sham acupuncture plus standard care group (SSC), and standard care group (SC). Patients in ASC and SSC will receive 9 sessions of acupuncture or sham acupuncture for 3 weeks, and will be followed up for 2 months. The primary measure is the change from baseline score of the Edmonton Symptom Assessment System at 3 weeks. The secondary measures include the Brief Fatigue Inventory, Hospital Anxiety and Depression Scale, Insomnia Severity Index, Numeric Rating Scale, and European Organization for Research and Treatment of Cancer Quality of Life 15 items Questionnaire for Palliative Care. Discussion: The finding of this trial will provide high-quality evidence on the adjunctive effect of acupuncture to standard care on advanced cancer patients undergoing palliative care. Trial Registration: Clinicaltrials.gov, NCT04398875 (https://www.clinicaltrials.gov/ct2/show/NCT04398875), Registered on 21 May 2020.-
dc.languageeng-
dc.publisherSAGE Publications (UK and US): Open Access Titles. The Journal's web site is located at http://www.sagepub.com/journalsProdDesc.nav?prodId=Journal201510-
dc.relation.ispartofIntegrative Cancer Therapies-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectacupuncture-
dc.subjectcancer related symptoms-
dc.subjectpalliative care-
dc.subjectquality of life-
dc.subjectrandomized controlled trial-
dc.titleThe Adjunctive Effect of Acupuncture for Advanced Cancer Patients in a Collaborative Model of Palliative Care: Study Protocol for a 3-Arm Randomized Trial-
dc.typeArticle-
dc.identifier.emailKong, FM: kong0001@hku.hk-
dc.identifier.authoritySo, TH=rp01981-
dc.identifier.authorityKong, FM=rp02508-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1177/15347354211012749-
dc.identifier.pmid33957783-
dc.identifier.pmcidPMC8113363-
dc.identifier.scopuseid_2-s2.0-85105499665-
dc.identifier.hkuros324302-
dc.identifier.volume20-
dc.identifier.spagearticle no. 15347354211012749-
dc.identifier.epagearticle no. 15347354211012749-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats